Antimicrobial resistance and genomic screening of clinical isolates of thermophilic Campylobacter spp. from south-east Queensland, Australia

J Appl Microbiol. 2003;94(3):495-500. doi: 10.1046/j.1365-2672.2003.01856.x.

Abstract

Aim: To screen 90 clinical isolates of thermophilic Campylobacter species for putative resistance to ampicillin, erythromycin and tetracycline and perform numerical analysis to determine isolate relatedness.

Methods and results: Disc diffusion, E-test MIC and agar dilution methods were performed. Disc diffusion testing showed 87 (97%) isolates appeared resistant to ampicillin at 10 microg; 14 (16%) resistant to tetracycline at 30 microg; and three (3.4%) resistant to erythromycin at 15 microg. E-test MICs showed a range of 0.5 to >256 mg l(-1) for ampicillin; 16 to >256 mg l(-1) for tetracycline; and >256 mg l(-1) for erythromycin. E-test showed 68% correlation (+/-1 log2 dilution) with agar dilution for ampicillin, 100% for erythromycin and 64% for tetracycline. Disc diffusion testing showed 100% correlation with agar dilution for erythromycin and tetracycline, and 77% for ampicillin. Numerical analyses of restriction endonuclease (RE) fragment profiles suggested a high level of isolate variation.

Conclusion: The incidence of resistance of thermophilic Campylobacter spp. to erythromycin and tetracycline is low in south-east Queensland.

Significance and impact of the study: Disc diffusion susceptibility testing may be used to screen thermophilic Campylobacter spp. for putative resistance to erythromycin and tetracycline. Agar dilution should be used to determine ampicillin susceptibility.

MeSH terms

  • Ampicillin Resistance / genetics
  • Campylobacter / drug effects*
  • Campylobacter / genetics
  • Cluster Analysis
  • DNA, Bacterial / analysis
  • Drug Resistance, Bacterial*
  • Erythromycin / pharmacology
  • Microbial Sensitivity Tests / methods
  • Restriction Mapping / methods
  • Tetracycline Resistance / genetics

Substances

  • DNA, Bacterial
  • Erythromycin